InvestorsHub Logo
Followers 7
Posts 2799
Boards Moderated 0
Alias Born 01/17/2010

Re: MrGreenStock$ post# 48060

Thursday, 12/23/2010 11:01:39 AM

Thursday, December 23, 2010 11:01:39 AM

Post# of 105534
IT platforms will make private banks family-related Registries; similar to the donor unrelated registry - Global! Cryo-Cell is trying to hold onto its S. America bluechip. Too little info is known today about the complaint filed by the affiant. It does however prove the value of that operation must be substantial.

Family Related Registry is the next Big Boom!

Families who have stored their stem cells for $2000 could get a call from a Pharma or a insurer in the not too distant future looking to acquire their sample for a figure between $15,000 to $30,000; just like the public bank. It could change the family private banking model as we know it today.
How much is a private family sample worth if it contains the HIV antigen? It depends on how much the insurer pays on average to treat a patient with pharma prescribed conventional meds.

I project a special sample with a high immunity (HIV resistence) could be worth maybe > $100,000 per sample.

If you stored a sample in a private bank don't be surprised to get a call from someone in the future asking if you'd sell it imo.

Public Registry gets $30k per sample but that was before the adult stem cell HIV cure.

To prevent this scenario from becoming the norm what must happen?

-Pharma, Insurance or Hospital must control the supply. The manufacturer with the most chips will have some very valuable assets for their customers. The customers will learn very quickly the value of those assets and awareness will take off like no other time in history. There are 30 million afflicted by HIV living today.

The first cure just happens to be an Adult Stem Cell derived from Cord Blood. Nice!
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.